Home > PE Ratio > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of SMS PHARMACEUTICALS is 36.29.

Share Price ₹251.0Nov 19,2024
Market Cap ₹2,125.5 Cr
Earnings-TTM₹58.6 CrTTM-Consolidated Results
Price/Earnings36.29xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of SMS PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SMS PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹2,125.5 Cr] as on Nov 19,2024

(/) Earnings [ ₹58.6 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 36.29x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SMS PHARMACEUTICALS , the investors are currently willing to pay 36.29 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SMS PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SMS PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of SMS PHARMACEUTICALS


PE Ratio Performance Analysis for SMS PHARMACEUTICALS

- SMS PHARMACEUTICALS 's latest p/e ratio is 36.29x.

- SMS PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 13.40x.

- SMS PHARMACEUTICALS 's operated at median p/e ratio of 12.76x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SMS PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 30.25x.

- SMS PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does SMS PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SMS PHARMACEUTICALS 58.5836.292,125.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5038.25425,930.0
CIPLA LTD4,485.2226.39118,368.0
DR REDDYS LABORATORIES LTD5,406.8018.4399,671.4
ZYDUS LIFESCIENCES LTD4,298.9022.1695,280.3
DIVIS LABORATORIES LTD1,836.0086.40158,636.0
MANKIND PHARMA LTD2,124.8648.42102,890.0
TORRENT PHARMACEUTICALS LTD1,802.0058.13104,742.0
LUPIN LTD2,651.9435.0492,929.7
AUROBINDO PHARMA LTD3,598.8319.6970,869.4
ABBOTT INDIA LTD1,284.6644.9057,681.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SMS PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.43x
Max industry PE 86.40x
Median industry PE 36.29x
Average industry PE 39.46x



You may also like the below Video Courses